CD274 and neoplasm: Notably, the engineered humanized PDL1/4-1BB/TIGIT Tri-NAb shows encouraging therapeutic effects on patient-derived tumor organoids and humanized nice, highlighting the translational potential of synergistic NK and T cell (Fig. 1).